CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.863
-0.087 (-1.76%)
At close: Jul 19, 2024, 4:00 PM
4.950
+0.087 (1.79%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $55.70 million as of July 22, 2024. Its market cap has decreased by -39.26% in one year.
Market Cap
55.70M
Enterprise Value
35.50M
1-Year Change
-39.26%
Ranking
Category
Stock Price
$4.86
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has increased from $30.60M to $55.70M, an increase of 82.03%. That is a compound annual growth rate of 9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 55.70M | -23.91% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 57.77M |
| Neuronetics | 57.75M |
| Anebulo Pharmaceuticals | 57.05M |
| Cytosorbents | 57.02M |
| LENSAR | 56.07M |
| Rallybio | 55.54M |
| Passage Bio | 55.47M |
| OKYO Pharma | 55.17M |